Sumatriptan: Side Effects, Uses & Monitoring
Sumatriptan tablets are indicated for the acute treatment of migraine with or without aura in adults.
- Data source
- FDA labeling via NIH DailyMed (label f8c4bbfb…)
- Label version
- current
- Last reviewed
- 2026
Reported adverse reactions
Reactions listed in current FDA labeling, with the highest frequency reported across summarized placebo-controlled trials.
| Adverse reaction (as reported in labeling) | Reported frequency* |
|---|---|
| Pain and other pressure sensations | 8% |
| Sensation warm/cold | 5% |
| Other - pressure/tightness/ heaviness | 3% |
| Pain - location specified | 2% |
*Highest percentage reported for the active moiety across placebo-controlled trial tables in current FDA labeling. Values reflect trial reporting, not your individual risk.
Labeled uses (from FDA prescribing information)
Sumatriptan tablets are indicated for the acute treatment of migraine with or without aura in adults. Limitations of Use: Use only if a clear diagnosis of migraine headache has been established. If a patient has no response to the first migraine attack treated with sumatriptan tablets, reconsider the diagnosis of migraine before sumatriptan tablets are administered to treat any subsequent attacks. Sumatriptan tablets are not indicated for the prevention of migraine attacks. Safety and effectiveness of sumatriptan tablets have not been established for cluster headache.
Conditions associated with Sumatriptan in labeling
Frequently Asked Questions
What is Sumatriptan used for?
FDA labeling lists the approved uses shown above under "Labeled uses." This summary is informational; only a qualified prescriber can determine whether a medication is appropriate for you.
What are the most commonly reported side effects of Sumatriptan?
The table above shows adverse reactions and the highest frequencies reported in placebo-controlled trials summarized in current FDA labeling for Sumatriptan. Individual risk varies.
Does Sumatriptan require lab monitoring?
Monitoring needs vary. Ask your healthcare provider whether any lab tests apply while taking Sumatriptan.
Where does this information come from?
All clinical facts on this page were extracted from the current FDA-registered product labeling for this ingredient, published by manufacturers through NIH DailyMed. See the source link below.
Medical disclaimer: Educational content extracted from public FDA labeling. Not medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication.